Principles of perioperative coagulopathy

Best Practice and Research: Clinical Anaesthesiology

Volumn 24, Issue 1, 2010, Pages 1-14

  Innerhofer, Petra ^a   Kienast, Joachim ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

acidosis; coagulation factors; coagulation tests; fibrinogen; hypothermia; intravenous fluids; perioperative coagulopathy; platelets; viscoelastic methods

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRINOGEN; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOPLASTIN;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; DILUTION; HEMOSTASIS; HUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL PATIENT; THROMBOCYTE ACTIVATION; VISCOELASTICITY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL; BLOOD SUBSTITUTES; GUIDELINES AS TOPIC; HUMANS; PERIOPERATIVE CARE;

EID: 77249099876     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2009.09.006     Document Type: Review

References (85)

1. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 45 (2005) 33S-39S discussion 39S-40S
2. Clark D.A., Gorczynski R.M., and Blajchman M.A. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen. Transfusion 48 (2008) 814-821
3. Dunne J.R., Lee T.H., Burns C., et al. Transfusion-associated microchimerism in combat casualties. The Journal of Trauma 64 (2008) S92-S97 discussion S97-98
4. Gajic O., Gropper M.A., and Hubmayr R.D. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Critical Care Medicine 34 (2006) S109-S113
5. Adams G.L., Manson R.J., Turner I., et al. The balance of thrombosis and hemorrhage in surgery. Hematology/Oncology Clinics of North America 21 (2007) 13-24
6. Koscielny J., Ziemer S., Radtke H., et al. A practical concept for preoperative identification of patients with impaired primary hemostasis. Clinical and Applied Thrombosis/Hemostasis 10 (2004) 195-204
7. Knofler R., Olivieri M., Weickardt S., et al. First results of the THROMKID study: a quality project for the registration of children und adolescents with hereditary platelet function defects in Germany, Austria, and Switzerland. Hamostaseologie 27 (2007) 48-53
8. Schneppenheim R., and Budde U. Inborn and acquired von Willebrand disease. Hamostaseologie 28 (2008) 312-319
9. Pfanner G., Koscielny J., Pernerstorfer T., et al. Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care. Der Anaesthesist 56 (2007) 604-611
10. Liu N., and Kessler C. In: Kitchens C.S., Alving B., and Kessler C. (Eds). A systemic approach to the bleeding patient (2002), W.B. Saunders, Philadelphia
11. Budde U., Bergmann F., and Michiels J.J. Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry. Seminars in Thrombosis and Hemostasis 28 (2002) 227-238
12. Velik-Salchner C., Eschertzhuber S., Streif W., et al. Acquired von Willebrand syndrome in cardiac patients. Journal of Cardiothoracic and Vascular Anesthesia 22 (2008) 719-724
13. Dzik W.H. Predicting hemorrhage using preoperative coagulation screening assays. Current Hematology Reports 3 (2004) 324-330
14. Kitchens C.S. To bleed or not to bleed? Is that the question for the PTT?. Journal of Thrombosis and Haemostasis 3 (2005) 2607-2611
15. Peyvandi F., Cattaneo M., Inbal A., et al. Rare bleeding disorders. Haemophilia 14 Suppl. 3 (2008) 202-210
16. Li J., Shen H., Hou T., et al. Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature. Spine 34 (2009) E305-E308
17. Singbartl K., Innerhofer P., Radvan J., et al. Hemostasis and hemodilution: a quantitative mathematical guide for clinical practice. Anesthesia and Analgesia 96 (2003) 929-935 table of contents
18. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Reviews 17 Suppl. 1 (2003) S1-S5
19. Rivard G.E., Brummel-Ziedins K.E., Mann K.G., et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. Journal of Thrombosis and Haemostasis 3 (2005) 2039-2043
20. Ni H., Denis C.V., Subbarao S., et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. The Journal of Clinical Investigation 106 (2000) 385-392
21. Rojkjaer L.P., and Rojkjaer R. Clot stabilization for the prevention of bleeding. Hematology/Oncology Clinics of North America 21 (2007) 25-32
22. Mosesson M.W. Update on antithrombin I (fibrin). Thrombosis and Haemostasis 98 (2007) 105-108
23. Tanaka K.A., Taketomi T., Szlam F., et al. Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesthesia and Analgesia 106 (2008) 732-738 table of contents
24. Lewis N.R., Brunker P., Lemire S.J., et al. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage. Transfusion 49 (2009) 689-695
25. Collins P.W., Macchiavello L.I., Lewis S.J., et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. British Journal of Haematology 135 (2006) 220-227
26. Velik-Salchner C., Maier S., Innerhofer P., et al. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study. Anesthesia and Analgesia 108 (2009) 1747-1754
27. Mannucci P.M., Federici A.B., and Sirchia G. Hemostasis testing during massive blood replacement. A study of 172 cases. Vox Sanguinis 42 (1982) 113-123
28. Ciavarella D., Reed R.L., Counts R.B., et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. British Journal of Haematology 67 (1987) 365-368
29. Martini W.Z., Chinkes D.L., Pusateri A.E., et al. Acute changes in fibrinogen metabolism and coagulation after hemorrhage in pigs. American Journal of Physiology. Endocrinology and Metabolism 289 (2005) E930-E934
30. Hiippala S.T., Myllyla G.J., and Vahtera E.M. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia 81 (1995) 360-365
31. McLoughlin T.M., Fontana J.L., Alving B., et al. Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesthesia and Analgesia 83 (1996) 459-465
32. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84 (1996) 732-747
33. Stainsby D., MacLennan S., Thomas D., et al. Guidelines on the management of massive blood loss. British Journal of Haematology 135 (2006) 634-641
34. Nielsen V.G., Cohen B.M., and Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiologica Scandinavica 49 (2005) 222-231
35. Gerlach R., Tolle F., Raabe A., et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 33 (2002) 1618-1623
36. Blome M., Isgro F., Kiessling A.H., et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thrombosis and Haemostasis 93 (2005) 1101-1107
37. Karlsson M., Ternstrom L., Hyllner M., et al. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 48 (2008) 2152-2158
38. Charbit B., Mandelbrot L., Samain E., et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis 5 (2007) 266-273
39. Bolliger D., Szlam F., Molinaro R.J., et al. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. British Journal of Anaesthesia 102 (2009) 793-799
40. Weinstock N., and Ntefidou M. SSC International Collaborative Study to establish the first high fibrinogen plasma reference material for use with different fibrinogen assay techniques. Journal of Thrombosis and Haemostasis 4 (2006) 1825-1827
41. Hiippala S.T. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagulation & Fibrinolysis 6 (1995) 743-746
42. Mittermayr M., Streif W., Haas T., et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesthesia and Analgesia 105 (2007) 905-917 table of contents
43. Innerhofer P. Perioperative management of coagulation. Hamostaseologie 26 (2006) S3-14
44. Huissoud C., Carrabin N., Audibert F., et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG : An International Journal of Obstetrics and Gynaecology 116 (2009) 1097-1102
45. Velik-Salchner C., Haas T., Innerhofer P., et al. The effect of fibrinogen concentrate on thrombocytopenia. Journal of Thrombosis and Haemostasis 5 (2007) 1019-1025
46. Lang T., Johanning K., Metzler H., et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesthesia and Analgesia 108 (2009) 751-758
47. Al Dieri R., Peyvandi F., Santagostino E., et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thrombosis and Haemostasis 88 (2002) 576-582
48. Allen G.A., Wolberg A.S., Oliver J.A., et al. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. Journal of Thrombosis and Haemostasis 2 (2004) 402-413
49. Davidson S.J., Burman J.F., Philips S.M., et al. Correlation between thrombin potential and bleeding after cardiac surgery in adults. Blood Coagulation & Fibrinolysis 14 (2003) 175-179
50. Schols S.E., van der Meijden P.E., van Oerle R., et al. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding. Thrombosis and Haemostasis 99 (2008) 64-70
51. Monroe D.M. Modeling the action of factor VIIa in dilutional coagulopathy. Thrombosis Research 122 Suppl. 1 (2008) S7-S10
52. Horne III M.K., Merryman P.K., Cullinane A.M., et al. The impact of major surgery on blood coagulation factors and thrombin generation. American Journal of Hematology 82 (2007) 815-820
53. Burns E.R., Goldberg S.N., and Wenz B. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. American Journal of Clinical Pathology 100 (1993) 94-98
54. Chandler W.L., Patel M.A., Gravelle L., et al. Factor XIIIA and clot strength after cardiopulmonary bypass. Blood Coagulation & Fibrinolysis 12 (2001) 101-108
55. Wettstein P., Haeberli A., Stutz M., et al. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesthesia and Analgesia 99 (2004) 1564-1569 table of contents
56. Nielsen V.G., Gurley Jr. W.Q., and Burch T.M. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesthesia and Analgesia 99 (2004) 120-123
57. Brummel-Ziedins K.E., Pouliot R.L., and Mann K.G. Thrombin generation: phenotypic quantitation. Journal of Thrombosis and Haemostasis 2 (2004) 281-288
58. Maegele M. Frequency, risk stratification and therapeutic management of acute post-traumatic coagulopathy. Vox Sanguinis 97 (2009) 39-49
59. de Jonge E., and Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Critical Care Medicine 29 (2001) 1261-1267
60. Niemi T.T., and Kuitunen A.H. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiologica Scandinavica 49 (2005) 373-378
61. Innerhofer P., Fries D., Margreiter J., et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesthesia and Analgesia 95 (2002) 858-865 table of contents
62. Kozek-Langenecker S.A. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103 (2005) 654-660
63. Fries D., Innerhofer P., Klingler A., et al. The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 94 (2002) 1280-1287
64. Madjdpour C., Dettori N., Frascarolo P., et al. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics?. British Journal of Anaesthesia 94 (2005) 569-576
65. Treib J., Baron J.F., Grauer M.T., et al. An international view of hydroxyethyl starches. Intensive Care Medicine 25 (1999) 258-268
66. de Jonge E., Levi M., Berends F., et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thrombosis and Haemostasis 79 (1998) 286-290
67. Chappell D., Bruchelt W., Schenk W., et al. Development of spontaneous subdural hematoma and bone marrow depression after hydroxyethyl starch administration. The Journal of Pediatrics 153 (2008) 579-581
68. Fries D., Streif W., Margreiter J., et al. The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis. Blood Coagulation & Fibrinolysis 15 (2004) 213-219
69. Mittermayr M., Streif W., Haas T., et al. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. British Journal of Anaesthesia 100 (2008) 307-314
70. Nielsen V.G. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma. The Journal of Heart and Lung Transplantation 25 (2006) 1344-1352
71. Nielsen V.G. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiologica Scandinavica 49 (2005) 1163-1171
72. Ruttmann T.G. Haemodilution enhances coagulation. British Journal of Anaesthesia 88 (2002) 470-472
73. Brummel-Ziedins K., Whelihan M.F., Ziedins E.G., et al. The resuscitative fluid you choose may potentiate bleeding. The Journal of Trauma 61 (2006) 1350-1358
74. Kiraly L.N., Differding J.A., Enomoto T.M., et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. The Journal of Trauma 61 (2006) 57-64 discussion 64-55
75. Haas T., Fries D., Holz C., et al. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. Anesthesia and Analgesia 106 (2008) 1078-1086 table of contents
76. Haas T., Fries D., Velik-Salchner C., et al. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesthesia and Analgesia 106 (2008) 1360-1365 table of contents
77. Fenger-Eriksen C., Tonnesen E., Ingerslev J., et al. Mechanisms of hydroxyethyl starch induced dilutional coagulopathy. Journal of Thrombosis and Haemostasis 7 (2009) 1099-1105
78. De Lorenzo C., Calatzis A., Welsch U., et al. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesthesia and Analgesia 102 (2006) 1194-1200
79. Hardy J.F., De Moerloose P., and Samama M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Canadian Journal of Anaesthesia 51 (2004) 293-310
80. Lier H., Krep H., Schroeder S., et al. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. The Journal of Trauma 65 (2008) 951-960
81. Martini W.Z. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metabolism 56 (2007) 214-221
82. Meng Z.H., Wolberg A.S., Monroe III D.M., et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. The Journal of Trauma 55 (2003) 886-891
83. Michelson A.D., MacGregor H., Barnard M.R., et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thrombosis and Haemostasis 71 (1994) 633-640
84. Faraday N., and Rosenfeld B.A. In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression. Anesthesiology 88 (1998) 1579-1585
85. Martini W.Z., Dubick M.A., Pusateri A.E., et al. Does bicarbonate correct coagulation function impaired by acidosis in swine?. The Journal of Trauma 61 (2006) 99-106